Kechuang Medical's Microvascular Anastomosis Device Embarks on Global Journey from Mongolia

Recently, Kechuang Medical Group successfully conducted a training and hands-on session on the "Kecle 2.0" Microvascular Anastomosis Device at the National Cancer Hospital of Mongolia, marking the product's first step into the international market. During the training, physicians achieved a 100% patency rate in a chicken thigh vessel anastomosis experiment, garnering high praise from the hospital's experts. This successful entry into the Mongolian market represents a significant milestone in the globalization of domestically developed high-end medical devices and lays a solid foundation for Kechuang Medical's subsequent expansion into broader international markets, including Europe and the United States.